Sobre 3 señales de compra con un rendimiento T+90 consolidado. Base de rendimiento: cierre del día siguiente a la publicación.
Historial de señales
Browse the full record of transactions filed by Byam Rebecca, Director Financiero. Officer active across 1 company, notably HCW Biologics Inc.. Cumulatively, 25 disclosures have been recorded. Split: 21 buys · 0 sell. Total volume traded: €969k. Activity tracked since 22 July 2021. The latest transaction was disclosed on 22 May 2026 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Byam Rebecca
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25.000 títulos@ 8,00 US$8.8% de su flujoCommon StockSEC:0001209191-21-048079:0
Salida canónica: 20 oct 2021 (T+90)
25 de 25 declaraciones
About Byam Rebecca
Byam Rebecca is Director Financial at HCW Biologics Inc. She has filed 25 forms in total, and across the recent filings tracked between 2021-07-23 and 2026-05-27, the transactions are predominantly acquisitions, with EUR 968822 of buys and EUR 0 of sells.